These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 12650423)
1. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. Bulsara KR; McGirt MJ; Liao L; Villavicencio AT; Borel C; Alexander MJ; Friedman AH J Neurosurg; 2003 Mar; 98(3):524-8. PubMed ID: 12650423 [TBL] [Abstract][Full Text] [Related]
2. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. Lee VH; Connolly HM; Fulgham JR; Manno EM; Brown RD; Wijdicks EF J Neurosurg; 2006 Aug; 105(2):264-70. PubMed ID: 17219832 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. Deibert E; Barzilai B; Braverman AC; Edwards DF; Aiyagari V; Dacey R; Diringer M J Neurosurg; 2003 Apr; 98(4):741-6. PubMed ID: 12691398 [TBL] [Abstract][Full Text] [Related]
4. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Mayer SA; Lin J; Homma S; Solomon RA; Lennihan L; Sherman D; Fink ME; Beckford A; Klebanoff LM Stroke; 1999 Apr; 30(4):780-6. PubMed ID: 10187879 [TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. Mayer SA; LiMandri G; Sherman D; Lennihan L; Fink ME; Solomon RA; DiTullio M; Klebanoff LM; Beckford AR; Homma S J Neurosurg; 1995 Nov; 83(5):889-96. PubMed ID: 7472560 [TBL] [Abstract][Full Text] [Related]
6. Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction. Martinez EA; Nass CM; Jermyn RM; Rosenbaum SH; Akhtar S; Chan DW; Malkus H; Weiss JL; Fleisher LA J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):577-82. PubMed ID: 16202889 [TBL] [Abstract][Full Text] [Related]
7. The use of cardiac troponin-I (cTnI) to determine the incidence of myocardial ischemia and injury in patients with aneurysmal and presumed aneurysmal subarachnoid hemorrhage. Horowitz MB; Willet D; Keffer J Acta Neurochir (Wien); 1998; 140(1):87-93. PubMed ID: 9522914 [TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. Parekh N; Venkatesh B; Cross D; Leditschke A; Atherton J; Miles W; Winning A; Clague A; Rickard C J Am Coll Cardiol; 2000 Oct; 36(4):1328-35. PubMed ID: 11028491 [TBL] [Abstract][Full Text] [Related]
9. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Tung P; Kopelnik A; Banki N; Ong K; Ko N; Lawton MT; Gress D; Drew B; Foster E; Parmley W; Zaroff J Stroke; 2004 Feb; 35(2):548-51. PubMed ID: 14739408 [TBL] [Abstract][Full Text] [Related]
10. Preadmission beta-blockers are associated with decreased incidence of neurogenic stunned myocardium in aneurysmal subarachnoid hemorrhage. Liang CW; Chen R; Macri E; Naval N J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):601-7. PubMed ID: 22105019 [TBL] [Abstract][Full Text] [Related]
12. Neurogenic Stunned Myocardium Following Acute Subarachnoid Hemorrhage: Pathophysiology and Practical Considerations. Murthy SB; Shah S; Rao CP; Bershad EM; Suarez JI J Intensive Care Med; 2015 Sep; 30(6):318-25. PubMed ID: 24212600 [TBL] [Abstract][Full Text] [Related]
13. Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy. Miss JC; Kopelnik A; Fisher LA; Tung PP; Banki NM; Lawton MT; Smith WS; Dowd CF; Zaroff JG Neurosurgery; 2004 Dec; 55(6):1244-50; discussion 1250-1. PubMed ID: 15574206 [TBL] [Abstract][Full Text] [Related]
14. Ampulla cardiomyopathy associated with aneurysmal subarachnoid hemorrhage: report of 6 patients. Fujita K; Fukuhara T; Munemasa M; Numba Y; Kuyama H Surg Neurol; 2007 Nov; 68(5):556-61; discussion 561. PubMed ID: 17961746 [TBL] [Abstract][Full Text] [Related]
15. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study. Chalouhi N; Daou B; Okabe T; Starke RM; Dalyai R; Bovenzi CD; Anderson EC; Barros G; Reese A; Jabbour P; Tjoumakaris S; Rosenwasser R; Kraft WK; Rincon F J Neurosurg; 2016 Sep; 125(3):730-6. PubMed ID: 26799296 [TBL] [Abstract][Full Text] [Related]
16. [Neurogenic ventricular dysfunction and aneurysmatic subarachnoid hemorrhage]. Ruiz A; Fábregas N; Sala X; García C Rev Esp Anestesiol Reanim; 2006 Nov; 53(9):584-6. PubMed ID: 17297839 [No Abstract] [Full Text] [Related]
17. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Kothavale A; Banki NM; Kopelnik A; Yarlagadda S; Lawton MT; Ko N; Smith WS; Drew B; Foster E; Zaroff JG Neurocrit Care; 2006; 4(3):199-205. PubMed ID: 16757824 [TBL] [Abstract][Full Text] [Related]
18. Variant Neurogenic Stunned Myocardium in a Young Female After Subarachnoid Hemorrhage. Mahanna E; Edwards DA; Tarante N; Rahman M; Petersen JW; Bihorac A A A Case Rep; 2016 Jan; 6(1):10-3. PubMed ID: 26422453 [TBL] [Abstract][Full Text] [Related]
19. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty]. La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645 [TBL] [Abstract][Full Text] [Related]
20. Neurogenic Stress Cardiomyopathy After Aneurysmal Subarachnoid Hemorrhage. Malik AN; Gross BA; Rosalind Lai PM; Moses ZB; Du R World Neurosurg; 2015 Jun; 83(6):880-5. PubMed ID: 25655685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]